“…For this reason, additional uses of AMSA have been extrapolated, i.e. for identifying the presence of specific pathologies, like STEMI, although all the above conclusions derive, again, only from retrospective analyses with many limitations and selection biases [5,6,9,13]. Surprisingly, AMSA may become an almost complete clairvoyant during CPR, capable to predict not only defibrillation success but also comorbidities, drug assumptions, and even more, such as long term survival and neurological outcome.…”